Rongrong Zhou
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases (NCT06702826) | Rongrong Zhou | 2024-11-01 |
| Hypofractionated Radiotherapy for Thymic Epithelial Tumors (NCT06692062) | Rongrong Zhou | 2024-10-01 |
Track Rongrong Zhou automatically
Every clearance here is in the API, with alerts when new ones post.